Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-06-13
1997-12-02
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540586, A61K 3155, C07D49504
Patent
active
056936354
ABSTRACT:
Tricyclic compounds of the general Formula I: ##STR1## as defined herein which exhibit antagonist activity at V.sub.1 and/or V.sub.2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and processes for preparing such compounds.
REFERENCES:
International Union of Pure and Applied Chemistry (IUPAC), vol. 82, 1960, p. 5566.
Drug Evaluations, 6th Ed., 1986, Amer. Medical Assn., pp. 160-162.
Cecil Textbook of Medicine, 19th Ed., 1992, Wyngaarden, M.D., Editor, pp. 2075-2079.
Yamamura, et al., Science, 252, pp. 572-574, 1991.
Yamamura, et al., Br. J. Pharmacol., 105, pp.787-791 (1992).
Albright Jay Donald
Reich Marvin Fred
American Cyanamid Company
Datlow Philip I.
Eck Steven R.
LandOfFree
Tricyclic benzazepine vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic benzazepine vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic benzazepine vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-801421